Now on Android. Existing accounts work. Get it on Google Play.

Hydrochlorothiazide (HCTZ): nursing considerations

Hydrochlorothiazide (HCTZ) is a thiazide diuretic: it makes the kidneys get rid of more sodium and water, and it is used to lower blood pressure and edema. It can also cause low potassium and low sodium, so check electrolytes, especially potassium. It can raise blood glucose and uric acid. Taken by mouth, it increases urine output within 2 hours.⁠[1][2]

Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

Quick facts

Hydrochlorothiazide at a glance
FactHydrochlorothiazide
Drug class⁠[1][2]Thiazide diuretic
Used for⁠[1]High blood pressure, alone or with other drugs; add-on treatment for edema from heart failure, cirrhosis, or corticosteroid and estrogen therapy; also used for edema from kidney disease
Contraindicated with⁠[1]Anuria (no urine output); allergy to sulfonamide-derived drugs
Timing by mouth⁠[1][2]Urine output rises within 2 hours, peaks at about 4 hours, and stays up for about 6 to 12 hours
Check⁠[1][2]Blood pressure, electrolytes (especially potassium), kidney function, intake and output, and weight
Metabolic effects⁠[1]Higher glucose and uric acid; slightly higher calcium; possibly higher cholesterol and triglycerides

Before giving hydrochlorothiazide: potassium, sodium, and fluid status

  • As the kidneys get rid of sodium, some potassium may be lost in the urine too. Watch for fluid and electrolyte imbalance: low sodium, low potassium, and low chloride with a raised blood pH (hypochloremic alkalosis). Low potassium is more likely with fast, heavy urine output, severe cirrhosis, long-term use, or poor intake by mouth.⁠[1]
  • Low potassium can cause arrhythmias and makes the heart more sensitive to digoxin toxicity.⁠[1]
  • Encourage foods high in potassium. A potassium-sparing diuretic or a potassium supplement can also prevent or treat low potassium.⁠[1][2]
  • Warning signs of fluid and electrolyte imbalance include dry mouth, thirst, weakness, confusion, muscle cramps, low urine output, low blood pressure, and a fast heart rate.⁠[1]
  • Use caution in severe kidney disease, where thiazides can cause a buildup of waste in the blood (azotemia), and in liver disease, where small fluid and electrolyte shifts can bring on hepatic coma (coma caused by liver disease).⁠[1]

Report eye pain at once, and watch glucose, uric acid, and lithium

  • A sudden drop in vision or eye pain within hours to weeks of starting can be acute angle-closure glaucoma, which can cause permanent vision loss if untreated. The first treatment is stopping hydrochlorothiazide as quickly as possible, so report it right away.⁠[1]
  • It can raise blood glucose, so insulin or oral diabetes medicines may need adjusting, and it can raise uric acid or bring on gout.⁠[1]
  • Lithium generally isn't given with diuretics, because they slow how fast the kidneys clear lithium and put the patient at high risk of lithium toxicity.⁠[1]

Teach sun protection and slow position changes

  • Protect the skin from the sun and keep up regular skin cancer screening, because hydrochlorothiazide is linked to a higher risk of non-melanoma skin cancer.⁠[1]
  • Change positions slowly, take it at the same time each day, and report big weight changes.⁠[2]

The app's clinical tools include a drug reference for hydrochlorothiazide, built from its FDA label.

Browse clinical tools

How it shows up on nursing exams

  • Thiazides and loop diuretics lower potassium, and spironolactone raises it. In a patient taking digoxin, low potassium raises the risk of digoxin toxicity.⁠[1][2][3]
  • A sulfonamide allergy is a contraindication, and a history of sulfonamide or penicillin allergy may raise the risk of angle-closure glaucoma.⁠[1]

Practice question

A patient takes hydrochlorothiazide and digoxin. The laboratory reference ranges are potassium 3.5 to 5.1 mEq/L, glucose 62 to 125 mg/dL, and calcium 8.8 to 10.2 mg/dL. Which result should the nurse report to the health care provider first?

  1. A. Blood glucose 132 mg/dL
  2. B. Serum potassium 3.1 mEq/L
  3. C. Serum calcium 10.0 mg/dL
  4. D. Blood pressure 126/80 mm Hg
Show the answer and why

Correct answer: B. Serum potassium 3.1 mEq/L

  • A. Incorrect. 132 mg/dL is above the range, and hydrochlorothiazide can raise glucose, but a mild rise is less urgent than low potassium in a patient who takes digoxin.
  • B. Correct. 3.1 mEq/L is below the range. Hydrochlorothiazide can cause hypokalemia, and low potassium makes the heart more sensitive to digoxin toxicity. Report this first.
  • C. Incorrect. Thiazides can raise calcium slightly, but 10.0 mg/dL is inside the range.
  • D. Incorrect. Lower blood pressure is the intended effect, and this reading is not low.

Sources for this question: ⁠[1][4][5][6]

Memory hook: HCTZ lowers potassium and sodium, can raise glucose and uric acid, and calls for sun protection.

Questions about hydrochlorothiazide

Does hydrochlorothiazide lower potassium?

Yes, it can cause low potassium (hypokalemia), especially with fast, heavy urine output, severe cirrhosis, long-term use, or poor intake. Electrolytes are checked periodically, and foods high in potassium help prevent it.⁠[1][2]

Why should patients on hydrochlorothiazide protect their skin?

Hydrochlorothiazide is linked to a higher risk of non-melanoma skin cancer, so patients protect the skin from the sun and keep up regular skin cancer screening.⁠[1]

When does hydrochlorothiazide start working?

Taken by mouth, it increases urine output within 2 hours, with the peak at about 4 hours and the effect lasting about 6 to 12 hours.⁠[1][2]

Study this topic in MagstoneRN

Browse the pharmacology decks, practice question types, and clinical tools in the free app preview.

Open the free app preview
Start monthly 5-day trial

Payment method required. First-time subscribers only. After the trial, the plan costs $19.99/month until you cancel. You aren't charged if you cancel before the trial ends. Cancel anytime online.

MagstoneRN plans and trial terms

Sources for this page

All 6 sources
  1. Hydrochlorothiazide tablets USP, prescribing information (DailyMed version 20, June 12, 2026) (opens in a new tab). Leading Pharma, LLC, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed November 13, 2026.
  2. Nursing Pharmacology, 2nd edition, Chapter 6: Cardiovascular & Renal Systems (opens in a new tab). Open RN, Chippewa Valley Technical College (2023). License: CC BY 4.0. Accessed October 18, 2026.
  3. ALDACTONE (spironolactone) tablets, prescribing information (DailyMed version 25, November 28, 2025) (opens in a new tab). Pfizer Laboratories Div Pfizer Inc, on DailyMed (National Library of Medicine). License: U.S. drug label published on DailyMed; facts cited, no text reused. Accessed November 13, 2026.
  4. Potassium, default method (reference interval effective September 14, 2026) (opens in a new tab). UW Medicine Laboratory Test Guide. License: Not openly licensed; reference values cited as facts, no text reused. Accessed October 18, 2026.
  5. Glucose, default method (reference interval effective September 14, 2026) (opens in a new tab). UW Medicine Laboratory Test Guide. License: Not openly licensed; reference values cited as facts, no text reused. Accessed October 18, 2026.
  6. Calcium, default method (reference interval effective September 14, 2026) (opens in a new tab). UW Medicine Laboratory Test Guide. License: Not openly licensed; reference values cited as facts, no text reused. Accessed October 18, 2026.

MagstoneRN wrote this page from the sources listed here. MagstoneRN has not commissioned an independent clinical review of it.

A number in brackets links to the source for the fact it follows. How we source our content explains where the facts come from, and the educational use terms explain what study pages like this one are for.

Report a wrong or outdated fact through support so MagstoneRN can correct the page.

Sources: 6 entries, from FDA drug labels and reputable secondary sources, last accessed November 13, 2026.